Sirtuin 1 and 2 inhibitors enhance the inhibitory effect of sorafenib in hepatocellular carcinoma cells
María Paula Ceballos, Antonella Angel, Carla Beatriz Delprato, Verónica Inés Livore, Anabela C. Ferretti, Alvaro Lucci, Carla G. Comanzo, María de Luján Álvarez, Ariel D. Quiroga, Aldo D. Mottino, María Cristina Carrillo
Topics & Concepts
SorafenibHepatocellular carcinomaApoptosisCancer researchCyclin D1Viability assayPharmacologyCell growthCell cultureCell cycleBiologyMedicineBiochemistryGeneticsSirtuins and Resveratrol in MedicineEndoplasmic Reticulum Stress and DiseaseCancer-related Molecular Pathways